European journal of cancer (Oxford, England : 1990)HumansAdultFemaleMaleSarcoma
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907).
Yuki Kojima, Keisuke Watanabe, Motoko Arakaki, Tadaaki Nishikawa, Yukari Hoshina, Kenta Anjo, Akihiro Hirakawa, Masahiko Ichimura, Makoto Endo, Ikuo Kudawara, Masanobu Takahashi, Genki Okumura, Shohei Koyama, Akihiko Yoshida, Kouya Shiraishi
Published: 202610.1016/j.ejca.2025.116104
Abstract
PURPOSE: Alveolar soft part sarcoma (ASPS) is a rare subtype of soft tissue sarcoma with a high metastatic potential. We conducted a phase II clinical study of atezolizumab in ASPS patients to evaluate its efficacy, safety, and biomarkers associated…
Preview only. Read the full abstract at the source